Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Biol Chem ; 287(11): 8407-16, 2012 Mar 09.
Artigo em Inglês | MEDLINE | ID: mdl-22267745

RESUMO

Pannexin 1 (Panx1) is a novel gap junction protein shown to have tumor-suppressive properties. To model its in vivo role in the intratumor biomechanical environment, we investigated whether Panx1 channels modulate the dynamic assembly of multicellular C6 glioma aggregates. Treatment with carbenoxolone and probenecid, which directly and specifically block Panx1 channels, respectively, showed that Panx1 is involved in accelerating aggregate assembly. Experiments further showed that exogenous ATP can reverse the inhibitive effects of carbenoxolone and that aggregate compaction is sensitive to the purinergic antagonist suramin. With a close examination of the F-actin microfilament network, these findings show that Panx1 channels act as conduits for ATP release that stimulate the P(2)X(7) purinergic receptor pathway, in turn up-regulating actomyosin function. Using a unique three-dimensional scaffold-free method to quantify multicellular interactions, this study shows that Panx1 is intimately involved in regulating intercellular biomechanical interactions pivotal in the progression of cancer.


Assuntos
Citoesqueleto de Actina/metabolismo , Conexinas/metabolismo , Glioma/metabolismo , Proteínas de Neoplasias/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Transdução de Sinais , Citoesqueleto de Actina/genética , Actomiosina/genética , Actomiosina/metabolismo , Trifosfato de Adenosina/antagonistas & inibidores , Trifosfato de Adenosina/farmacologia , Animais , Antiulcerosos/farmacologia , Carbenoxolona/antagonistas & inibidores , Carbenoxolona/farmacologia , Linhagem Celular Tumoral , Conexinas/genética , Antagonismo de Drogas , Glioma/genética , Camundongos , Proteínas de Neoplasias/genética , Proteínas do Tecido Nervoso/genética , Probenecid/antagonistas & inibidores , Probenecid/farmacologia , Receptores Purinérgicos P2X7/genética , Receptores Purinérgicos P2X7/metabolismo , Uricosúricos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA